Characteristics of Patient Groups
| Patient Group . | Total No. . | Age at Plasma . | Mean . | Length of fVIII . | Mean . | Immunosuppressants . |
|---|---|---|---|---|---|---|
| . | . | Sampling . | . | Treatment . | . | . |
| HA-pdfVIII | 17 | 2-68 | 27 | 1.25-65 | 20 | 1 of 17 |
| HA-rfVIII | 11 | 0.4-4.5 | 1.9 | 0.25-3.3 | 1.9 | None |
| AA | 15 | 22-84 | 55 | 10, none; 3, little | NA | 9 of 15 |
| Patient Group . | Total No. . | Age at Plasma . | Mean . | Length of fVIII . | Mean . | Immunosuppressants . |
|---|---|---|---|---|---|---|
| . | . | Sampling . | . | Treatment . | . | . |
| HA-pdfVIII | 17 | 2-68 | 27 | 1.25-65 | 20 | 1 of 17 |
| HA-rfVIII | 11 | 0.4-4.5 | 1.9 | 0.25-3.3 | 1.9 | None |
| AA | 15 | 22-84 | 55 | 10, none; 3, little | NA | 9 of 15 |
The age at plasma sampling, length of fVIII treatment, and means are given in years.
Abbreviation: NA, not applicable.